Search results for:

16 results

Het federale regeerakkoord door een publiekrechtelijke bril

De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises client in the pharmaceutical sector

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Stibbe advises leading plasma protein biotherapeutics company

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe advises biotech company

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

Stibbe advises major pharmaceutical company

Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.

Stibbe advises Cellerix

Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.

The latest Legal Updates straight to your mailbox

We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.

Digital Law Up(to)date: No processing of vaccination status in recruitment process

The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.

Stibbe advises Avista Capital Partners

Stibbe advised Avista Capital Partners on the acquistion of a 50% stake in Vision Healthcare.

SearchSearch results for: “”